A Phase III Clinical Trial for Efficacy, Immunogenicity, Safety and Immune Persistence of Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children Aged From 6-15 Years Old.
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Helicobacter pylori vaccine (Primary)
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- Sponsors Wuhu Kangwei Biological Technology
- 03 Sep 2015 New trial record
- 02 Jul 2015 Results published online in the Lancet.